BAXTER INTERNATIONAL INC
For the period ended Mar 31, 2026. Filed Apr 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows (unaudited)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operations | ||
| Net income (loss) | $(15) | $126 |
| Less: Income (loss) from discontinued operations, net of tax | 2 | 62 |
| Income (loss) from continuing operations | (17) | 64 |
| Adjustments to reconcile net income (loss) to cash flows from operations: | ||
| Depreciation and amortization | 237 | 247 |
| Deferred income taxes | 29 | (142) |
| Stock compensation | 10 | 10 |
| Net periodic pension and other postretirement costs | (4) | (8) |
| Other long-lived asset impairments | — | 22 |
| Other | 13 | 6 |
| Changes in balance sheet items: | ||
| Accounts receivable, net | 152 | 26 |
| Inventories | (95) | (122) |
| Prepaid expenses and other current assets | 2 | (24) |
| Accounts payable | 102 | 16 |
| Accrued expenses and other current liabilities | (203) | (143) |
| Other | (13) | (51) |
| Cash flows from (used in) operations - continuing operations | 213 | (99) |
| Cash flows from (used in) operations - discontinued operations | — | (94) |
| Cash flows from (used in) operations | 213 | (193) |
| Cash flows from investing activities | ||
| Capital expenditures | (137) | (122) |
| Other investing activities, net | 4 | (2) |
| Cash flows from (used in) investing activities - continuing operations | (133) | (124) |
| Cash flows from (used in) investing activities - discontinued operations | — | 3,389 |
| Cash flows from (used in) investing activities | (133) | 3,265 |
| Cash flows from financing activities | ||
| Repayments of debt | — | (2,825) |
| Repayments of debt with original maturities of three months or less | — | (300) |
| Cash dividends on common stock | (5) | (87) |
| Proceeds from stock issued under employee benefit plans | 8 | 10 |
| Other financing activities, net | (14) | (24) |
| Cash flows from (used in) financing activities | (11) | (3,226) |
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash - continuing operations | (18) | 36 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 51 | (118) |
| Cash, cash equivalents and restricted cash at beginning of period (1) | 1,968 | 2,414 |
| Cash, cash equivalents and restricted cash at end of period (1) | 2,019 | 2,296 |
| Less cash and cash equivalents of discontinued operations | — | — |
| Cash, cash equivalents and restricted cash of continuing operations | $2,019 | $2,296 |
(1)The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of March 31, 2026, December 31, 2025, and March 31, 2025 (in millions):
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Cash and cash equivalents | $2,017 | $1,966 | $2,294 |
| Restricted cash included in other non-current assets | 2 | 2 | 2 |
| Cash, cash equivalents and restricted cash | $2,019 | $1,968 | $2,296 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.